CNM-Au8 in amyotrophic lateral sclerosis: the HEALEY ALS Platform Trial
用户fSY_E3R3uQNw
2个月前
83
10
已完结
1. 系统已在2025-12-22 15:53:06对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://jamanetwork.com/journals/jama/fullarticle/2830508
其他信息:
D Hayden, PY Lai, RA Donahue, HW Chen, J Wang…
JAMA, 2025
jamanetwork.com
… CNM-Au8 treatment group (−2.3% in plasma and 0.4% in serum). The differences in change comparing the placebo and CNM-Au8 … of CNM-Au8 on amyotrophic lateral sclerosis disease …
